+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Disposable Fully Automatic Biopsy Device Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6080950
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The disposable fully automatic biopsy device market represents a significant leap forward in diagnostic precision and procedural efficiency. Advanced engineering has yielded devices capable of streamlining tissue sampling workflows, reducing procedure time, and minimizing patient discomfort. By integrating fully automated mechanisms, these devices eliminate manual variability, ensure consistent sample quality, and support a broad spectrum of clinical environments. This introduction sets the stage for an in-depth exploration of the forces reshaping the market, from cutting-edge technological breakthroughs and regulatory shifts to evolving reimbursement landscapes and geopolitical factors. As demand for minimally invasive diagnostics continues to rise, stakeholders must understand how these disposable platforms will redefine clinical protocols, enhance safety standards, and influence strategic decision-making. Subsequent sections will unpack transformative trends, tariff impacts, segmentation complexities, regional dynamics, leading competitors, and concrete recommendations for leveraging emerging opportunities and navigating challenges in this rapidly maturing field.

Transformative Shifts Redefining Biopsy Technology

Over the past decade, the biopsy device landscape has undergone dramatic transformation driven by technological convergence, heightened regulatory scrutiny, and growing emphasis on patient-centric care. Fully automated devices now incorporate real-time imaging guidance, artificial intelligence-enabled needle placement, and adaptive feedback mechanisms that calibrate penetration depth and sample volume. Regulatory bodies worldwide have responded by accelerating approval pathways for single-use devices that mitigate cross-contamination risk and align with stringent sterilization mandates. In parallel, clinicians have embraced minimally invasive alternatives that reduce complication rates and facilitate outpatient workflows. Collaboration between device manufacturers, imaging software developers, and academic institutions has spurred innovation cycles, resulting in next-generation cartridges, ergonomic handpieces, and integrated data-capture platforms. This confluence of technological, regulatory, and clinical imperatives has reshaped procurement criteria, shifted budget allocations, and positioned disposable fully automatic biopsy devices as a cornerstone of contemporary interventional diagnostics.

Cumulative Impact of U.S. 2025 Tariffs on Market Dynamics

In 2025, U.S. tariff adjustments introduced new cost variables across medical device supply chains. Import duties on key raw materials and subassemblies have pressured manufacturers to reassess sourcing strategies, with downstream effects on device pricing and distribution agreements. Some production has migrated to regions with preferential trade agreements to mitigate elevated import duties, while others have pursued vertical integration to secure critical components in-house. Reimbursement frameworks have also adapted, with payers reevaluating covered procedure codes to reflect increased acquisition costs. Hospitals and ambulatory centers are negotiating volume-based discounts and performance-based contracts to stabilize per-procedure expenses. Despite initial margin compression, manufacturers that proactively optimized manufacturing footprints and negotiated cross-border partnerships have preserved competitive pricing. As stakeholders recalibrate cost models and supply chain networks, the market is evolving toward greater resilience and agility, ensuring uninterrupted patient access to advanced biopsy solutions.

Key Segmentation Insights Driving Market Complexity

The fully automatic biopsy device market is defined by multiple interlocking segmentation dimensions that collectively drive purchasing behavior and innovation pathways. Based on product type, the landscape comprises reusable powered apparatus available in both non-rechargeable battery-operated and rechargeable battery-operated configurations; spring-loaded apparatus differentiated by multiple-use and single-use designs; and vacuum-assisted apparatus split between electric-biopsy and pneumatic-biopsy models. Considering needle type, practitioners choose between aspiration needle systems offered in fine-gauge variants such as 20G and 22G, and core needle systems available in fine gauges like 14G and 18G, each tailored for specific tissue consistencies. Application segments range from breast biopsy procedures guided by mammography, MRI, or ultrasound to kidney interventions executed via laparoscopic or percutaneous approaches; liver sampling conducted percutaneously or through transjugular access; lung biopsies performed transbronchially or transthoracically; and prostate tissue extraction via transperineal or transrectal routes. End users include ambulatory surgical centers in both rural and urban settings, clinics specializing in gastroenterology or oncology, and hospitals from general care facilities to specialized institutions. Channels of distribution span direct procurement through bulk or individual purchase agreements, collaborations with multi-brand or single-brand distributors, and digital fulfillment via e-commerce or supplier websites. Material composition influences durability and cost, with stainless steel and titanium alloys juxtaposed against plastics such as polycarbonates and polypropylene. Finally, technological orientation divides conventional manual spring-loaded devices from advanced systems featuring automation-guided or computer-assisted controls. This multifaceted segmentation framework underpins tailored product launches, targeted marketing campaigns, and strategic resource allocation across the value chain.

Regional Dynamics and Growth Hotspots

Regional dynamics underscore the critical importance of geographical strategy in the disposable biopsy device domain. In the Americas, established healthcare infrastructures and favorable reimbursement policies for minimally invasive diagnostics have fueled rapid adoption of single-use, fully automated platforms, especially in centers of excellence and specialized cancer institutes. Robust R&D ecosystems in North America facilitate local prototypes and pilot programs, while Latin American markets exhibit growing interest amid investments in outpatient surgery centers. In Europe, Middle East & Africa, stringent regulations on device sterilization and environmental waste management have spurred demand for disposable solutions that meet evolving eco-compliance standards. Market expansion in Western Europe is driven by bundled procurement agreements among hospital networks, and emerging markets in Africa are witnessing increased governmental support for oncology screening initiatives. Asia-Pacific presents a dynamic mix of advanced urban centers and rural healthcare settings; leading economies prioritize automation-enhanced devices to offset skilled-labor shortages, whereas developing nations focus on cost-effective solutions and local manufacturing partnerships. Across all regions, cross-border collaborations and knowledge transfer programs continue to accelerate device customization to meet diverse clinical protocols and regulatory requirements.

Leading Players Shaping the Competitive Landscape

The competitive landscape features a diverse array of innovators and established medical device conglomerates. Argon Medical Devices, Inc. and Devicor Medical Products leverage specialized design expertise to introduce modular biopsy systems, while Bard Biopsy Systems under the umbrella of Becton, Dickinson and Company and C. R. Bard, Inc. offer comprehensive portfolios that integrate needle and device compatibility testing. Biopsybell S.R.L. and Cook Medical Inc. focus on precision-engineered handpieces and proprietary safety mechanisms. Boston Scientific Corporation and Medtronic plc emphasize end-to-end solutions, linking automated sample acquisition with digital pathology platforms. CareFusion Corporation, now part of Becton, Dickinson, and Company, and Hologic, Inc. drive innovation in single-use cartridges and imaging-enhanced guidance systems. Fujifilm Holdings Corporation applies its imaging heritage to real-time visualization modules, while Integra LifeSciences Holdings Corporation and Merit Medical Systems, Inc. prioritize ergonomic design and workflow integration. Stryker Corporation broadens its surgical systems portfolio through automation-enabled biopsy attachments. Across these competitors, differentiation emerges through patent-protected mechanisms, strategic alliances, and tiered pricing models, compelling continuous product refinement and commercialization speed.

Actionable Recommendations for Industry Leadership

To capitalize on emerging opportunities and mitigate evolving risks, industry leaders should adopt a multifaceted strategic roadmap. First, establish flexible manufacturing networks that combine regional production hubs with distributed assembly lines to buffer against tariff fluctuations and transportation disruptions. Second, invest in modular design platforms that allow rapid customization of device form factors, needle gauges, and guidance interfaces to address unique clinical protocols and customer preferences. Third, deepen integration with digital health ecosystems by embedding connectivity features that capture procedural data, support remote monitoring, and facilitate interoperability with electronic medical records. Fourth, pursue co-development agreements with imaging and pathology technology partners to create end-to-end diagnostic workflows that elevate clinical outcomes and justify premium pricing. Fifth, implement value-based contracting models that align reimbursement with procedural efficacy, sample adequacy rates, and patient satisfaction metrics. Finally, reinforce sustainability initiatives by adopting eco-friendly materials and participating in post-use recycling programs, thereby enhancing brand reputation and meeting tightening environmental regulations.

Conclusion

The disposable fully automatic biopsy device market stands at an inflection point characterized by accelerating technology adoption, complex regulatory landscapes, and heightened competitive pressures. Innovations in automation, imaging integration, and single-use safety protocols are redefining how tissue sampling is performed across clinical settings. Concurrently, geopolitical events and tariff reforms are prompting supply chain realignments and manufacturing localization. In this dynamic environment, success will hinge on agility, strategic partnerships, and unwavering commitment to clinical excellence and patient safety. As end users demand seamless workflows and healthcare systems prioritize cost-effective diagnostics, manufacturers must continuously refine their value propositions through data-driven design, flexible commercialization strategies, and sustainable practices. By embracing these imperatives, stakeholders can secure leadership positions in a market that promises to transform interventional diagnostics and improve patient outcomes worldwide.

Market Segmentation & Coverage

This research report categorizes the Disposable Fully Automatic Biopsy Device Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Reusable Powered Apparatus
    • Non-Rechargeable Battery Operated
    • Rechargeable Battery-Operated
  • Spring-Loaded Apparatus
    • Multiple Use
    • Single Use
  • Vacuum-Assisted Apparatus
    • Electric-Biopsy Device
    • Pneumatic-Biopsy Device
  • Aspiration Needle
    • Fine Gauge
      • 20G
      • 22G
    • Standard Gauge
  • Core Needle
    • Fine Gauge
      • 14G
      • 18G
    • Standard Gauge
  • Breast Biopsy
    • Mammography-Guided
    • MRI-Guided
    • Ultrasound-Guided
  • Kidney Biopsy
    • Laparoscopic
    • Percutaneous
  • Liver Biopsy
    • Percutaneous
    • Transjugular
  • Lung Biopsy
    • Transbronchial
    • Transthoracic
  • Prostate Biopsy
    • Transperineal
    • Transrectal
  • Ambulatory Surgical Centers
    • Rural ASCs
    • Urban ASCs
  • Clinics
    • Gastroenterology Clinics
    • Oncology Clinics
  • Hospital
    • General Hospitals
    • Specialized Hospitals
  • Direct Procurement
    • Bulk Purchase
    • Individual Purchase
  • Distributors
    • Multi-Brand Distributors
    • Single-Brand Distributors
  • Online Platforms
    • E-commerce Websites
    • Supplier Websites
  • Metal
    • Stainless Steel
    • Titanium
  • Plastic
    • Polycarbonates
    • Polypropylene
  • Advanced
    • Automaton-Guided
    • Computer-Assisted
  • Conventional
    • Manual Spring-Loaded

This research report categorizes the Disposable Fully Automatic Biopsy Device Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Disposable Fully Automatic Biopsy Device Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Argon Medical Devices, Inc.
  • Bard Biopsy Systems (Becton, Dickinson and Company)
  • Biopsybell S.R.L.
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • CareFusion Corporation (a subsidiary of Becton, Dickinson and Company)
  • Cook Medical Inc.
  • Devicor Medical Products (a subsidiary of Leica Biosystems)
  • Fujifilm Holdings Corporation
  • Hologic, Inc.
  • Integra LifeSciences Holdings Corporation
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Stryker Corporation

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Disposable Fully Automatic Biopsy Device Market, by Product Type
8.1. Introduction
8.2. Reusable Powered Apparatus
8.2.1. Non-Rechargeable Battery Operated
8.2.2. Rechargeable Battery-Operated
8.3. Spring-Loaded Apparatus
8.3.1. Multiple Use
8.3.2. Single Use
8.4. Vacuum-Assisted Apparatus
8.4.1. Electric-Biopsy Device
8.4.2. Pneumatic-Biopsy Device
9. Disposable Fully Automatic Biopsy Device Market, by Needle Type
9.1. Introduction
9.2. Aspiration Needle
9.2.1. Fine Gauge
9.2.1.1. 20G
9.2.1.2. 22G
9.2.2. Standard Gauge
9.3. Core Needle
9.3.1. Fine Gauge
9.3.1.1. 14G
9.3.1.2. 18G
9.3.2. Standard Gauge
10. Disposable Fully Automatic Biopsy Device Market, by Application
10.1. Introduction
10.2. Breast Biopsy
10.2.1. Mammography-Guided
10.2.2. MRI-Guided
10.2.3. Ultrasound-Guided
10.3. Kidney Biopsy
10.3.1. Laparoscopic
10.3.2. Percutaneous
10.4. Liver Biopsy
10.4.1. Percutaneous
10.4.2. Transjugular
10.5. Lung Biopsy
10.5.1. Transbronchial
10.5.2. Transthoracic
10.6. Prostate Biopsy
10.6.1. Transperineal
10.6.2. Transrectal
11. Disposable Fully Automatic Biopsy Device Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.2.1. Rural ASCs
11.2.2. Urban ASCs
11.3. Clinics
11.3.1. Gastroenterology Clinics
11.3.2. Oncology Clinics
11.4. Hospital
11.4.1. General Hospitals
11.4.2. Specialized Hospitals
12. Disposable Fully Automatic Biopsy Device Market, by Channel
12.1. Introduction
12.2. Direct Procurement
12.2.1. Bulk Purchase
12.2.2. Individual Purchase
12.3. Distributors
12.3.1. Multi-Brand Distributors
12.3.2. Single-Brand Distributors
12.4. Online Platforms
12.4.1. E-commerce Websites
12.4.2. Supplier Websites
13. Disposable Fully Automatic Biopsy Device Market, by Material
13.1. Introduction
13.2. Metal
13.2.1. Stainless Steel
13.2.2. Titanium
13.3. Plastic
13.3.1. Polycarbonates
13.3.2. Polypropylene
14. Disposable Fully Automatic Biopsy Device Market, by Technology
14.1. Introduction
14.2. Advanced
14.2.1. Automaton-Guided
14.2.2. Computer-Assisted
14.3. Conventional
14.3.1. Manual Spring-Loaded
15. Americas Disposable Fully Automatic Biopsy Device Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Disposable Fully Automatic Biopsy Device Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Disposable Fully Automatic Biopsy Device Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Argon Medical Devices, Inc.
18.3.2. Bard Biopsy Systems (Becton, Dickinson and Company)
18.3.3. Biopsybell S.R.L.
18.3.4. Boston Scientific Corporation
18.3.5. C. R. Bard, Inc.
18.3.6. CareFusion Corporation (a subsidiary of Becton, Dickinson and Company)
18.3.7. Cook Medical Inc.
18.3.8. Devicor Medical Products (a subsidiary of Leica Biosystems)
18.3.9. Fujifilm Holdings Corporation
18.3.10. Hologic, Inc.
18.3.11. Integra LifeSciences Holdings Corporation
18.3.12. Medtronic plc
18.3.13. Merit Medical Systems, Inc.
18.3.14. Stryker Corporation
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET MULTI-CURRENCY
FIGURE 2. DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET MULTI-LANGUAGE
FIGURE 3. DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY NEEDLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY NEEDLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY REUSABLE POWERED APPARATUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY NON-RECHARGEABLE BATTERY OPERATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY RECHARGEABLE BATTERY-OPERATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY REUSABLE POWERED APPARATUS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SPRING-LOADED APPARATUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MULTIPLE USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SPRING-LOADED APPARATUS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY VACUUM-ASSISTED APPARATUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ELECTRIC-BIOPSY DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PNEUMATIC-BIOPSY DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY VACUUM-ASSISTED APPARATUS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ASPIRATION NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY 20G, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY 22G, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY STANDARD GAUGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ASPIRATION NEEDLE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY 14G, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY 18G, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY STANDARD GAUGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MAMMOGRAPHY-GUIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MRI-GUIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PERCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY KIDNEY BIOPSY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LIVER BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PERCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TRANSJUGULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LIVER BIOPSY, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TRANSBRONCHIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TRANSTHORACIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LUNG BIOPSY, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TRANSPERINEAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TRANSRECTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PROSTATE BIOPSY, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY RURAL ASCS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY URBAN ASCS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SPECIALIZED HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DIRECT PROCUREMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY BULK PURCHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY INDIVIDUAL PURCHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DIRECT PROCUREMENT, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MULTI-BRAND DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SINGLE-BRAND DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY E-COMMERCE WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SUPPLIER WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY METAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TITANIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PLASTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY POLYCARBONATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ADVANCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY AUTOMATON-GUIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY COMPUTER-ASSISTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ADVANCED, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MANUAL SPRING-LOADED, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY REUSABLE POWERED APPARATUS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SPRING-LOADED APPARATUS, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY VACUUM-ASSISTED APPARATUS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ASPIRATION NEEDLE, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY KIDNEY BIOPSY, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LIVER BIOPSY, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LUNG BIOPSY, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PROSTATE BIOPSY, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DIRECT PROCUREMENT, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ADVANCED, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY REUSABLE POWERED APPARATUS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SPRING-LOADED APPARATUS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY VACUUM-ASSISTED APPARATUS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ASPIRATION NEEDLE, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY KIDNEY BIOPSY, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LIVER BIOPSY, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LUNG BIOPSY, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PROSTATE BIOPSY, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DIRECT PROCUREMENT, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ADVANCED, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY REUSABLE POWERED APPARATUS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SPRING-LOADED APPARATUS, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY VACUUM-ASSISTED APPARATUS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ASPIRATION NEEDLE, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY KIDNEY BIOPSY, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LIVER BIOPSY, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LUNG BIOPSY, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PROSTATE BIOPSY, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DIRECT PROCUREMENT, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ADVANCED, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 187. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY REUSABLE POWERED APPARATUS, 2018-2030 (USD MILLION)
TABLE 189. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SPRING-LOADED APPARATUS, 2018-2030 (USD MILLION)
TABLE 190. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY VACUUM-ASSISTED APPARATUS, 2018-2030 (USD MILLION)
TABLE 191. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 192. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ASPIRATION NEEDLE, 2018-2030 (USD MILLION)
TABLE 193. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 194. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 195. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 196. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 198. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY KIDNEY BIOPSY, 2018-2030 (USD MILLION)
TABLE 199. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LIVER BIOPSY, 2018-2030 (USD MILLION)
TABLE 200. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LUNG BIOPSY, 2018-2030 (USD MILLION)
TABLE 201. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PROSTATE BIOPSY, 2018-2030 (USD MILLION)
TABLE 202. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 204. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 205. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 206. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DIRECT PROCUREMENT, 2018-2030 (USD MILLION)
TABLE 208. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 209. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 210. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 211. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
TABLE 212. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 213. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ADVANCED, 2018-2030 (USD MILLION)
TABLE 215. CANADA DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 216. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY REUSABLE POWERED APPARATUS, 2018-2030 (USD MILLION)
TABLE 218. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SPRING-LOADED APPARATUS, 2018-2030 (USD MILLION)
TABLE 219. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY VACUUM-ASSISTED APPARATUS, 2018-2030 (USD MILLION)
TABLE 220. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 221. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ASPIRATION NEEDLE, 2018-2030 (USD MILLION)
TABLE 222. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 223. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 224. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 225. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 227. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY KIDNEY BIOPSY, 2018-2030 (USD MILLION)
TABLE 228. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LIVER BIOPSY, 2018-2030 (USD MILLION)
TABLE 229. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LUNG BIOPSY, 2018-2030 (USD MILLION)
TABLE 230. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PROSTATE BIOPSY, 2018-2030 (USD MILLION)
TABLE 231. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 233. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 234. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 235. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DIRECT PROCUREMENT, 2018-2030 (USD MILLION)
TABLE 237. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 238. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 239. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 240. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
TABLE 241. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 242. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ADVANCED, 2018-2030 (USD MILLION)
TABLE 244. MEXICO DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY REUSABLE POWERED APPARATUS, 2018-2030 (USD MILLION)
TABLE 247. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SPRING-LOADED APPARATUS, 2018-2030 (USD MILLION)
TABLE 248. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY VACUUM-ASSISTED APPARATUS, 2018-2030 (USD MILLION)
TABLE 249. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 250. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ASPIRATION NEEDLE, 2018-2030 (USD MILLION)
TABLE 251. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 252. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 253. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY FINE GAUGE, 2018-2030 (USD MILLION)
TABLE 254. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 256. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY KIDNEY BIOPSY, 2018-2030 (USD MILLION)
TABLE 257. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LIVER BIOPSY, 2018-2030 (USD MILLION)
TABLE 258. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY LUNG BIOPSY, 2018-2030 (USD MILLION)
TABLE 259. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PROSTATE BIOPSY, 2018-2030 (USD MILLION)
TABLE 260. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 262. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 263. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 264. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DIRECT PROCUREMENT, 2018-2030 (USD MILLION)
TABLE 266. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 267. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 268. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 269. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
TABLE 270. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 271. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY ADVANCED, 2018-2030 (USD MILLION)
TABLE 273. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY CONVENTIONAL, 2018-2030 (USD MILLION)
TABLE 274. UNITED STATES DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY REUSABLE POWERED APPARATUS, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY SPRING-LOADED APPARATUS, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY VACUUM-ASSISTED APPARATUS, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC DISPOSABLE FULLY AUTOMATIC BIOPSY DEVICE MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)

Companies Mentioned

  • Argon Medical Devices, Inc.
  • Bard Biopsy Systems (Becton, Dickinson and Company)
  • Biopsybell S.R.L.
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • CareFusion Corporation (a subsidiary of Becton, Dickinson and Company)
  • Cook Medical Inc.
  • Devicor Medical Products (a subsidiary of Leica Biosystems)
  • Fujifilm Holdings Corporation
  • Hologic, Inc.
  • Integra LifeSciences Holdings Corporation
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Stryker Corporation

Methodology

Loading
LOADING...